{"disease":{"id":"seasonal-affective-disorder","name":"Seasonal affective disorder","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"chembl-chembl894","indication_name":"Prevention of Seasonal Affective Disorder (SAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"BUPROPION","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"bupropion-sr-150mg-bid","indication_name":"Prevention of Seasonal Affective Disorder (SAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupropion SR 150mg bid","company_name":"Massachusetts General Hospital","drug_phase":"marketed","molecular_target":"Dopamine transporter (DAT), Norepinephrine transporter (NET)","drug_class":"Atypical antidepressant, Norepinephrine-dopamine reuptake inhibitor (NDRI)","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"bupropion-immediate-release-ir","indication_name":"Seasonal Affective Disorder (SAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"bupropion immediate release (IR)","generic_name":"bupropion-immediate-release-ir","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Dopamine transporter, Norepinephrine transporter","drug_class":"Norepinephrine-dopamine reuptake inhibitor","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"bupropion","indication_name":"Seasonal affective disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellbutrin","generic_name":"bupropion","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"NDRI (Norepinephrine-dopamine reuptake inhibitor)","quality_score":55,"revenue":null,"mechanism":"Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects."},{"drug_id":"wellbutrin","indication_name":"Seasonal affective disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Wellbutrin","company_name":"Mclean Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"elontril","indication_name":"Seasonal affective disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elontril","company_name":"Boehringer Ingelheim","drug_phase":"phase_3","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03691792","title":"Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT00016666","title":"Clinical Trial of Propranolol for Seasonal Affective Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT04251000","title":"Infrared Photomodulation Therapy for Seasonal Affective Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"ProofPilot","has_results":false},{"nct_id":"NCT07161570","title":"Virtual Reality Digital Therapeutics for Seasonal Affective Disorder","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Anglia Ruskin University","has_results":false},{"nct_id":"NCT01462305","title":"30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Philips Respironics","has_results":true},{"nct_id":"NCT03313674","title":"Investigation of Seasonal Variations of Brain Structure and Connectivity in SAD","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT03403959","title":"Seasonal Affective Disorder and Visual Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Psychiatric Centre Rigshospitalet","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}